🇺🇸 FDA
Patent

US 7589181

Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use

granted A61PA61P35/00

Quick answer

US patent 7589181 (Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61P, A61P35/00